In 2025, staff augmentation has become a cornerstone of operational strategy in the life sciences industry. As the sector evolves at an unprecedented pace, driven by advances in biotechnology, personalized medicine, and digital health, the need for specialized talent has never been greater.
When developing medical devices, clinical trials are a crucial step in determining safety and effectiveness. These trials must comply with regulatory requirements, which vary depending on whether the device is classified as a significant risk (SR) or nonsignificant risk (NSR) device. This classification affects the need for an Investigational Device Exemption (IDE), a regulatory pathway that allows investigational devices to be tested in clinical studies.
Mammograms play a vital role in the early detection of breast cancer, helping to reduce mortality rates by identifying abnormalities in breast tissue before they can be felt. To ensure the safety, efficacy, and quality of mammography technology, the FDA maintains stringent regulations over mammogram machines and facilities. In this blog, we’ll explore how mammogram technology works and how the FDA regulates it to ensure patient safety.
Medical devices embedded with magnets play a pivotal role in modern healthcare, offering innovative solutions for diagnostics, therapy, and patient management. However, their usage comes with specific regulatory challenges to ensure safety and efficacy. This blog explores the regulations surrounding medical devices with magnets, their significance, and the evolving landscape of compliance.
From pacemakers to diagnostic tools, medical devices play a crucial role in improving patient outcomes and enhancing the quality of healthcare delivery worldwide. But who ensures that these devices meet rigorous standards and regulations? Enter the International Medical Device Regulators Forum (IMDRF), a global collaborative platform dedicated to harmonizing regulatory practices and promoting public health.
In this blog, we’ll explore what personalized medicine is, its significance in healthcare, and how the FDA regulates it to ensure safety and efficacy.
Within the European Union (EU), the regulation of combination medical device and drug products is meticulously governed by a comprehensive framework to ensure patient safety, efficacy, and regulatory compliance.
In this blog, we will explore how AI/ML is revolutionizing the medical device industry and the FDA’s plans for regulating this dynamic space.
Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing healthcare, offering unprecedented opportunities to improve patient outcomes, streamline processes, and enhance diagnostic accuracy. As AI and ML continue to make significant strides in the medical field, the U.S. Food and Drug Administration (FDA) plays a pivotal role in regulating these innovations. In this blog post, we’ll explore the intersection of AI/ML and medical devices, and how the FDA is navigating this rapidly evolving landscape.
Earlier this month, the Ministry of Health and Family Welfare, Government of India released a draft of the Drugs, Medical Devices and Cosmetics Bill, 2022 (“Bill”).[i] This Bill overhauls the pre-independence legislation enacted by the Central Legislative Assembly, the Drugs and Cosmetics Act, 1940,[ii] (“D&CA”) which is the primary legislation for regulation of drugs, biologics and medical devices at the moment.